查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466355

研究抗體市場：按適應症、按操作、按產品、按來源、按技術、按類型、按最終用戶 - 2024-2030 年，全球預測

Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

研究抗體市場規模預計2023年為62.7億美元，預計2024年將達到67.9億美元，2030年將達到110.5億美元，複合年成長率為8.43%。

研究抗體市場是指圍繞科學研究目的抗體的生產、分銷和應用的全球產業。抗體是免疫系統用來辨識和平衡細菌和病毒等外來物質的蛋白質。在研究中，抗體可用於多種應用，包括西方印漬術、流式細胞技術、免疫沉澱、螢光和 ELISA。這些抗體的最終用途通常出現在製藥和生物技術公司、學術研究機構和受託研究機構中。由於它們用途廣泛，市場規模較大，需要開發創新且高度特異性的抗體來滿足多樣化的研究需求。研究抗體市場的成長受到多種因素的影響，包括基因組學和蛋白​​質組學研究的日益普及、研究抗體的臨床試驗和核准的增加以及製藥和生物技術公司對研發的投資不斷增加。然而，研究抗體市場面臨著諸如高品質研究抗體的高生產和採購成本、與研究抗體相關的品質問題以及關於在抗體生產中使用動物的法規的增加等挑戰。另一方面，個人化醫療和生物標記的普及、開發新藥投資和資金籌措的增加以及從傳統多株抗體到基因工程抗體的轉變將為未來幾年的研究抗體市場帶來潛力。

主要市場統計
基準年[2023] 62.7億美元
預測年份 [2024] 67.9億美元
預測年份 [2030] 110.5億美元
複合年成長率（%） 8.43%

偏好越來越傾向於免疫學研究抗體，旨在闡明自體免疫疾病

在免疫學中，研究抗體是用於研究免疫系統組成部分的重要工具，包括 T 細胞和 B 細胞等細胞類型、細胞激素等訊號蛋白以及各種免疫途徑。對免疫學的需求通常是由了解自體免疫疾病、過敏和免疫力缺乏的需要所驅動的。用於感染疾病研究的抗體主要用於研究人體對病原體的反應以及識別和表徵病原體本身。整體而言，對抗新出現的感染疾病和流行病的抗體的需求量很大。有效的抗體開發可以改善診斷、疫苗和治療方法。在神經生物學領域，研究抗體促進了腦功能、神經退化性疾病和精神疾病的研究。針對神經元標記物、神經傳導物質和受體的抗體需求量很大，尤其是針對阿茲海默症和帕金森氏症等疾病。抗體對於癌症研究至關重要，包括腫瘤學腫瘤標記識別、癌細胞訊號傳導和免疫腫瘤學。不斷尋求更有效的癌症診斷和治療方法推動了需求。幹細胞研究抗體用於識別和分離幹細胞、區分幹細胞類型並追蹤分化途徑。幹細胞研究是一個快速發展的領域，需求集中在再生醫學和發育生物學研究。比較每個領域的指標表明，根據疾病領域的複雜性和每個領域的進展速度，對研究抗體的需求存在很大差異。由於對抗自體免疫疾病和癌症的持續挑戰，免疫學和腫瘤學是一直需求量大的領域。相反，為了應對新的健康危機，感染疾病的需求通常會激增。神經生物學和幹細胞研究處於科學發現的前沿，需要高度專業化的抗體來解決獨特的研究問題。神經生物學中大腦和中樞神經系統的複雜性以及幹細胞生物學的動態性質需要抗體製造商不斷創新。

最終用戶：擴大研究抗體在製藥和生技公司的使用

學術和研究機構需要抗體用於多種目的，包括基礎研究、疾病研究和教育目的。由於這些機構的研究主題廣泛，他們更喜歡價格實惠且具有多種特異性和用途的抗體。該細分市場專注於教育折扣和機構交易，並且經常尋求大量購買選擇。在製藥和生物技術領域，藥物發現和藥物開發過程需要高品質、高重複性和經過驗證的抗體。他們的需求主要集中在治療性抗體開發、生物標記發現和體外診斷。因此，在高通量和臨床環境中具有保證性能的高級、專用抗體是首選。將學術和研究機構與製藥和生物技術公司進行比較時，研究抗體需求存在一些重要差異。在學術和研究機構，研究主題往往更加多樣化和多樣化，因此抗體需要具有多功能性和成本效益。相較之下，製藥和生技公司優先考慮抗體的重現性和可靠性，特別是當它們在治療研究和診斷方面面臨嚴格的監管要求時。

區域洞察

在美國，對高品質研究抗體的需求強勁，主要是由於大型製藥公司的存在、生物技術和生命科學領域的集中研發工作以及政府和私營部門的大量投資。著名的資助機構美國國立衛生研究院 (NIH) 繼續採取舉措支持生物醫學研究，這對抗體市場產生了積極影響。加拿大市場的特點是生物技術產業不斷發展，政府對醫學研究的資助不斷增加。南美洲的研究抗體市場正在發展，由於醫療保健系統的改善、政府和私人研究支持的增加以及非傳染性疾病的增加，巴西和阿根廷等國家推動了該地區的需求。歐盟國家擁有完善的製藥和生物技術產業以及強大的學術研究活動，因此對研究型抗體的需求很高。然而，嚴格的監管政策可能會限制市場成長。注重研究活動的創新和永續性仍然是歐洲國家（包括英國、英國和法國）的中心趨勢。隨著醫療保健和研究基礎設施投資的增加，中東研究抗體市場正在不斷發展。非洲研究抗體市場相對開拓，具有巨大的成長潛力。由於新興經濟體、醫療保健資金的增加和研究領域的擴大，亞太地區的市場正在快速成長。中國的抗體市場正在快速成長，生物製藥研發投入龐大，學名藥產業蓬勃發展。日本擁有成熟的製藥業和創新傳統，使其成為研究抗體的重要市場。日本以其高標準的研究而聞名，客戶需要具有高特異性和重現性的抗體。印度是一個快速發展的市場，生物相似藥研究激增，生物技術產業蓬勃發展。

FPNV定位矩陣

FPNV定位矩陣對於評估研究抗體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對研究抗體市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估及資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.研究抗體市場的市場規模和預測是多少？

2.在研究抗體市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3. 研究抗體市場的技術趨勢和法規結構是什麼？

4.研究抗體市場主要廠商的市場佔有率為何？

5.進入研究型抗體市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基因組學和蛋白​​質組學研究日益普及
      • 研究抗體的臨床試驗和核准不斷增加
    • 抑制因素
      • 抗體開發過程耗時且成本高昂
    • 機會
      • 個人化醫療和生物標記的普及
      • 加大開發新藥投入與資金投入
    • 任務
      • 與研究抗體相關的品質問題
  • 市場區隔分析
    • 適應症：越來越傾向免疫學研究抗體來了解自體免疫疾病
    • 最終用戶：擴大研究抗體在製藥和生技公司的使用
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章 研究抗體市場：依跡象分類

  • 免疫學
  • 感染疾病
  • 神經生物學
  • 腫瘤學
  • 幹細胞

第7章 研究抗體市場：依營運分類

  • 藥物開發
  • 基因組學
  • 蛋白質體學

第8章研究抗體市場：依產品

  • 單株抗體
  • 多株抗體

第 9 章 研究抗體市場：依來源分類

  • 山羊
  • 老鼠
  • 兔子

第10章研究抗體市場：依技術分類

  • 酵素免疫分析法
  • 流式細胞技術
  • 螢光
  • 免疫組織化學
  • 免疫沉澱分析法
  • 蛋白質印跡法

第11章研究抗體市場：按類型

  • 一抗
  • 二抗

第12章 研究抗體市場：依最終用戶

  • 學術研究所
  • 製藥和生物技術公司

第13章美洲抗體市場研究

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太研究抗體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章歐洲、中東和非洲研究抗體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 丹納赫完成收購 Abcam
    • 艾伯維 (AbbVie) 和 Big Hat Biosciences 宣布開展研究合作，利用人工智慧和機器學習發現下一代治療抗體
    • AbCellera 和加拿大投資超過 5 億美元加強抗體生產和研究

第17章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4312A385A328

[182 Pages Report] The Research Antibodies Market size was estimated at USD 6.27 billion in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030.

The market for research antibodies refers to the global industry that revolves around the production, distribution, and application of antibodies for scientific research purposes. Antibodies are proteins utilized by the immune system to recognize and balance foreign substances, such as bacteria and viruses. In the research context, antibodies can be used in multiple applications, such as western blotting, flow cytometry, immunoprecipitation, immunofluorescence, and ELISA. The end-use for these antibodies is typically found in pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The broad application base provides a wide market scope, with demand driving the development of innovative and high-specific antibodies for diverse research needs. The growth of the research antibodies market is influenced by several factors, including the rising popularity of genomics and proteomics research, increasing clinical trials and approvals of research antibodies, and heightened investment in R&D by pharmaceutical and biotech firms. However, the research antibodies market faces certain challenges, such as the high cost of production and procurement of high-quality research antibodies, quality concerns associated with research antibodies, and tightening regulations regarding the use of animals in antibody production. On the other hand, the proliferation of personalized medicine and biomarkers, increasing investment and funding for novel drug development, and the shift from traditional polyclonal antibodies to recombinant antibodies present potential opportunities for the research antibodies market in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 6.27 billion
Estimated Year [2024] USD 6.79 billion
Forecast Year [2030] USD 11.05 billion
CAGR (%) 8.43%

Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases

In immunology, research antibodies are essential tools used to study the components of the immune system, including cell types such as T cells and B cells, signaling proteins, including cytokines, and various immunological pathways. Demand in immunology is frequently driven by the need to understand autoimmune diseases, allergies, and immune deficiencies. Research antibodies for infectious diseases are predominantly utilized to investigate the body's responses to pathogens and to identify and characterize the pathogens themselves. Demand is typically high for antibodies that can help combat emerging infectious diseases and pandemics. Effective antibody development can lead to improved diagnostics, vaccines, and therapies. In the neurobiology segment, research antibodies facilitate the study of brain function, neurodegenerative diseases, and psychiatric disorders. Antibodies against neuronal markers, neurotransmitters, and receptors are in high demand, particularly for illnesses such as Alzheimer's and Parkinson's. Oncology research antibodies are critical for cancer research, including tumor marker identification, cancer cell signaling, and immuno-oncology. Demand is driven by the ongoing search for more effective cancer diagnostics and treatments. Research antibodies directed at stem cells are used to identify and isolate stem cells, differentiate between stem cell types, and track differentiation pathways. Stem cell research is a rapidly progressing field, with demand often focusing on regenerative medicine and developmental biology studies. When comparing indicators across the spectrum, it's apparent that the need for research antibodies varies significantly depending on the complexity of the disease area and the rate of advancements in each field. Immunology and oncology are perennially high-demand sectors due to the ongoing challenges in combating autoimmune diseases and cancer. Conversely, infectious diseases see demand spikes typically in response to emerging health crises. Neurobiology and stem cell research can be categorized as frontiers of scientific discovery, requiring highly specialized antibodies to address unique research challenges. The complexity of the brain and central nervous system in neurobiology and the dynamic nature of stem cell biology necessitates constant innovation from antibody manufacturers.

End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies

Academic and research institutes predominantly require antibodies for various applications such as basic research, disease studies, and educational purposes. These institutions favor antibodies that are both affordable and offer a wide variety of specificities and applications, given the breadth of research topics pursued. This segment often seeks bulk purchasing options, emphasizing educational discounts and institutional deals. The pharmaceutical and biotechnology sector demands high-quality, reproducible, and validated antibodies for drug discovery and development processes. Their needs mainly focus on therapeutic antibody development, biomarker discovery, and in vitro diagnostics. Thus, their preference leans toward premium and specialized antibodies that guarantee performance in high-throughput and clinical settings. When comparing academic and research institutes to pharmaceutical and biotechnology companies, several key differences in research antibody requirements arise. Academic and research institutes often have more diverse and variable research interests, thus seeking versatility and cost-effectiveness in their antibodies. In contrast, pharmaceutical and biotechnology companies prioritize the reproducibility and reliability of antibodies, given the stringent regulatory requirements they face, particularly for therapeutic research and diagnostics.

Regional Insights

In the United States, there is a robust demand for high-quality research antibodies, primarily due to the presence of major pharmaceutical companies, a strong focus on R&D in biotechnology and life sciences, and significant government and private investment. The National Institutes of Health (NIH), a prominent funding body, has a continuing initiative to support biomedical research, which positively impacts the antibody market. Canada's market is characterized by a growing biotechnology industry and increased government funding in medical research. In South America, the research antibodies market is evolving, with countries such as Brazil and Argentina spearheading regional demand due to improving healthcare systems, increased governmental and private support for research, and a rise in non-communicable diseases. EU countries exhibit a strong demand for research antibodies due to well-established pharmaceutical and biotech industries, alongside extensive academic research activities. However, stringent regulatory policies may impose limitations on the market's growth. Focus on innovation and sustainability within research practices remains a central trend in European countries, including Germany, the UK, and France. The research antibody market in the Middle East is evolving with increasing investment in healthcare and research infrastructure. Africa's research antibody market is relatively untapped, with significant potential for growth. The APAC region exhibits rapid market growth due to emerging economies, increased healthcare funding, and expanding research sectors. China's antibody market is rapidly growing, with significant investments in biopharmaceutical R&D and a flourishing generics industry. Japan has an established pharmaceutical sector with a tradition of innovation, making it a significant market for research antibodies. Japan is known for its high standards in research practices, leading customers to demand antibodies with high specificity and reproducibility. India presents a rapidly evolving market with a surge in biosimilar research and a burgeoning biotech industry.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Research Antibodies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Research Antibodies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Absolute Antibody Ltd., Agilent Technologies, Inc., AvantGen, Inc., Becton, Dickinson and Company, Bio X Cell, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GenScript Corporation, Jackson ImmunoResearch Inc., Merck KGaA, PerkinElmer, Inc., PROGEN Biotechnik GmbH, Proteintech Group, Inc., QIAGEN N.V., Santa Cruz Biotechnology Inc., Synaptic Systems GmbH, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Research Antibodies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Stem Cells
  • Operation
    • Drug Development
    • Genomics
    • Proteomics
  • Product
    • Monoclonal Antibodies
    • Polyclonal Antibodies
  • Source
    • Goat
    • Mouse
    • Rabbit
  • Technology
    • Enzyme-Linked Immunosorbent Assay
    • Flow Cytometry
    • Immunofluorescence
    • Immunohistochemistry
    • Immunoprecipitation
    • Western Blotting
  • Type
    • Primary Antibodies
    • Secondary Antibodies
  • End User
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Research Antibodies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Research Antibodies Market?

3. What are the technology trends and regulatory frameworks in the Research Antibodies Market?

4. What is the market share of the leading vendors in the Research Antibodies Market?

5. Which modes and strategic moves are suitable for entering the Research Antibodies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Popularity of Genomics and Proteomics Research
      • 5.1.1.2. Increasing Clinical Trials and Approvals of Research Antibodies
    • 5.1.2. Restraints
      • 5.1.2.1. Time and Cost Consuming Antibody Development Processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of Personalized Medicine and Biomarkers
      • 5.1.3.2. Increasing Investment and Funding for Novel Drug Development
    • 5.1.4. Challenges
      • 5.1.4.1. Quality Concerns Associated with Research Antibodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases
    • 5.2.2. End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Research Antibodies Market, by Indication

  • 6.1. Introduction
  • 6.2. Immunology
  • 6.3. Infectious Diseases
  • 6.4. Neurobiology
  • 6.5. Oncology
  • 6.6. Stem Cells

7. Research Antibodies Market, by Operation

  • 7.1. Introduction
  • 7.2. Drug Development
  • 7.3. Genomics
  • 7.4. Proteomics

8. Research Antibodies Market, by Product

  • 8.1. Introduction
  • 8.2. Monoclonal Antibodies
  • 8.3. Polyclonal Antibodies

9. Research Antibodies Market, by Source

  • 9.1. Introduction
  • 9.2. Goat
  • 9.3. Mouse
  • 9.4. Rabbit

10. Research Antibodies Market, by Technology

  • 10.1. Introduction
  • 10.2. Enzyme-Linked Immunosorbent Assay
  • 10.3. Flow Cytometry
  • 10.4. Immunofluorescence
  • 10.5. Immunohistochemistry
  • 10.6. Immunoprecipitation
  • 10.7. Western Blotting

11. Research Antibodies Market, by Type

  • 11.1. Introduction
  • 11.2. Primary Antibodies
  • 11.3. Secondary Antibodies

12. Research Antibodies Market, by End User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Pharmaceutical & Biotechnology Companies

13. Americas Research Antibodies Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Research Antibodies Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Research Antibodies Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Danaher Completes Acquisition of Abcam
    • 16.3.2. AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
    • 16.3.3. AbCellera and Canada to invest $500M+ to boost antibody manufacturing and research

17. Competitive Portfolio

  • 17.1. Key Company Profiles
  • 17.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RESEARCH ANTIBODIES MARKET RESEARCH PROCESS
  • FIGURE 2. RESEARCH ANTIBODIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RESEARCH ANTIBODIES MARKET DYNAMICS
  • FIGURE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 24. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 29. RESEARCH ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 30. RESEARCH ANTIBODIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESEARCH ANTIBODIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 332. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 338. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 355. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD